Lundquist Inst BioMed at Harbor is a clinical research site located in Torrance, California, United States 90509-2910.
Crixeo Health Trust Score: 65/100 (FAIR). This profile has not yet been claimed by the site owner.
Lundquist Inst BioMed at Harbor has participated in 7 clinical trials with 4 currently active.
Therapeutic areas: Relapse Remitting Multiple Sclerosis, Proliferative Diabetic Retinopathy, Chronic Myelogenous Leukemia - Chronic Phase.
Sponsors: Novartis Pharmaceuticals.
Trust Score: 65/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Lundquist Inst BioMed at Harbor has a Crixeo Trust Score of 65/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Lundquist Inst BioMed at Harbor has 7 clinical trials on record, with 4 currently active. Their work covers Relapse Remitting Multiple Sclerosis, Proliferative Diabetic Retinopathy, Chronic Myelogenous Leukemia - Chronic Phase.
Lundquist Inst BioMed at Harbor has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.